Activating mutations of FLT3 include both internal tandem duplication (FLT3-ITD) and point mutations of the activation loop domain (FLT3-TKD), with a prevalence of ~15 and 7%, respectively, in pediatric AML (12). Here, FLT3 is linked to acute myeloid leukemia.